← Company directory

Series B

Lindus Health

AI-powered clinical trials / CRO tech (techbio-adjacent - borderline scope); Clinical trials / CRO technology (AI-enabled)

CandidateSeries BLondon

Latest disclosed round

Series B

Date
2025-01-21
Amount
USD 55m
Sector
Biotech & techbio; Healthtech & digital health
Companies House
13298185

Evidence status

Review retained

Identity
Candidate
Match
High candidate
Operating status
active
Data origins
Core directory, Growth Network, Live Chris T D1

Capital network

6 linked investors

Funding record

1 disclosed round

DateStageAmountInvestors
2025-01-21Series B$55MBalderton Capital, Visionaries Club, Creandum, firstminute Capital, Seedcamp

Traceability

Source trail

Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.